Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 25, 1995 - Issue 10
18
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat. Its effects on hepatic and pulmonary P450 and associated enzymes

, &
Pages 1051-1062 | Received 22 Mar 1995, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

H Xie, P Afsharian, Y Terelius, R. A Mirghani, Ü Yasar, A-L Hagbjörk, S Lundgren, Y Hu, A Rane & M Hassan. (2005) Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat. Xenobiotica 35:3, pages 239-251.
Read now

Articles from other publishers (2)

Ahmed Sabry S. Abdoon, Ahmed M.E Al-Atrash, Seham S. Soliman, Amro M. El-Sanea, Amina A. Gamal el Din & Hossam M. Fahmy. (2023) Lyophilized equine platelet-rich plasma (L-GFequina) antagonize the Reproductive toxicity and oxidative stress Induced by Cyclophosphamide in female rats. Journal of Ovarian Research 16:1.
Crossref
Parvaneh Afsharian, Ylva Terelius, Zuzana Hassan, Christina Nilsson, Stefan Lundgren & Moustapha Hassan. (2007) The Effect of Repeated Administration of Cyclophosphamide on Cytochrome P450 2B in Rats. Clinical Cancer Research 13:14, pages 4218-4224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.